Researchers are tackling the enormous global health problem of malaria through innovative approaches to develop new vaccine and drug candidates.
About half the world’s population is at risk of Malaria – caused by Plasmodium parasites and transmitted by certain species of mosquito found in tropical and sub-tropical regions. In 2015, the World Health Organization reported that a shocking 438,000 people died of this disease, mainly children under five years of age.
The malaria vaccination team at Griffith’s University are focused on seeing these numbers drop, determined to achieve global elimination of the disease. They have just finished clinical trials this year and have been working closely with expert infectious disease clinicians at Gold Coast University Hospital. This is the second round of clinical trials to be conducted by the Institute for Glycomics to examine malaria vaccine strategies in humans.
Malaria vaccine team leader Professor Michael Good said in order to achieve malaria elimination his team needs to think differently in their approach to research.
“To develop new vaccines, new drugs and new ways to deliver these therapies and to monitor their effects,” he said.
In the past decade, the number of deaths due to malaria has more than halved and the team wants to ensure this momentum is maintained.
Read more here: Griffith University.